Header Logo

Connection

Venkateshwar Madka to Humans

Back to Details
This is a "connection" page, showing publications Venkateshwar Madka has written about Humans.
Venkateshwar Madka
Connection Strength
0.320
Humans
  1. Chromatin Remodulator CHD4: A Potential Target for Cancer Interception. Genes (Basel). 2025 Feb 15; 16(2).
    View in: PubMed
    Score: 0.054
  2. Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models. Cells. 2024 Aug 31; 13(17).
    View in: PubMed
    Score: 0.053
  3. Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model. Cancer Prev Res (Phila). 2020 02; 13(2):185-194.
    View in: PubMed
    Score: 0.038
  4. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice. Neoplasia. 2013 Aug; 15(8):966-74.
    View in: PubMed
    Score: 0.024
  5. Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Curr Cancer Drug Targets. 2013 Jun; 13(5):542-57.
    View in: PubMed
    Score: 0.024
  6. Cancer stem cell markers as potential targets for epithelial cancers. Indian J Exp Biol. 2011 Nov; 49(11):826-35.
    View in: PubMed
    Score: 0.022
  7. Targeting Triglyceride Metabolism for Colorectal Cancer Prevention and Therapy. Curr Drug Targets. 2022; 23(6):628-635.
    View in: PubMed
    Score: 0.011
  8. Molecular Mechanisms of Cancer Prevention by Gooseberry (Phyllanthus emblica). Nutr Cancer. 2022; 74(7):2291-2302.
    View in: PubMed
    Score: 0.011
  9. Naproxen inhibits spontaneous lung adenocarcinoma formation in KrasG12V mice. Neoplasia. 2021 06; 23(6):574-583.
    View in: PubMed
    Score: 0.011
  10. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials. Int J Mol Sci. 2020 Dec 17; 21(24).
    View in: PubMed
    Score: 0.010
  11. Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention. Mol Carcinog. 2019 10; 58(10):1908-1918.
    View in: PubMed
    Score: 0.009
  12. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention. Semin Cancer Biol. 2019 06; 56:168-174.
    View in: PubMed
    Score: 0.009
  13. Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives. Int J Mol Sci. 2018 Aug 08; 19(8).
    View in: PubMed
    Score: 0.009
  14. Current Challenges and Opportunities for Chemoprevention of Pancreatic Cancer. Curr Med Chem. 2018; 25(22):2535-2544.
    View in: PubMed
    Score: 0.008
  15. Prevention and treatment of cancers by immune modulating nutrients. Mol Nutr Food Res. 2016 06; 60(6):1275-94.
    View in: PubMed
    Score: 0.007
  16. Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. Cancer Res. 2016 04 01; 76(7):1965-74.
    View in: PubMed
    Score: 0.007
  17. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Oncol Rep. 2015 Dec; 34(6):2925-34.
    View in: PubMed
    Score: 0.007
  18. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. Cancer Prev Res (Phila). 2014 Dec; 7(12):1198-209.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.